3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
4
Phase 2
2
Phase 3
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
7
Lymphoid
6
Sarcoma
3
Other hematologic neoplasm
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
263
Leukemia
190
Leukemia, Lymphocytic, Chronic, B-Cell
166
Precursor Cell Lymphoblastic Leukemia-Lymphoma
154
Myelodysplastic Syndromes
83
Lymphoma
79
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
71
Hematologic Neoplasms
62
Lymphoma, Non-Hodgkin
61
Lymphoma, Follicular
54
Leukemia, Myeloid, Chronic-Phase
53
Burkitt Lymphoma
51
Lymphoma, Large B-Cell, Diffuse
47
Lymphoma, B-Cell, Marginal Zone
45
Lymphoma, Mantle-Cell
44
Multiple Myeloma
42
Leukemia, Myelomonocytic, Chronic
41
Hodgkin Disease
41
Myeloproliferative Disorders
38
Neoplasms
37
Lymphoma, Large-Cell, Immunoblastic
37
Recurrence
31
Leukemia, Myeloid, Accelerated Phase
28
Congenital Abnormalities
27
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
26
Leukemia, Biphenotypic, Acute
26
Lymphoma, T-Cell, Cutaneous
25
Blast Crisis
24
Waldenstrom Macroglobulinemia
23
Leukemia, Myelomonocytic, Acute
23
Interventions
hydrocortisone hemisuccinate
1
Vincristine
1
Razoxane
1
Radiotherapy
1
Prednisone
1
Methotrexate
1
Mercaptopurine
1
Leucovorin
1
Hydrocortisone
1
Doxorubicin
1
Dexrazoxane
1
Cytarabine
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Cardiotoxicity
×
Other hematologic neoplasm
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled